Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada

B TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company, today announced the commercial launch of…
posteditor
posteditor
Articles: 21727

Other News